Genetically modified host cells producing violacein, analogues, and derivatives thereof
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of an industrially viable method for producing violacein and its analogues, which are of significant commercial and scientific interest due to their broad range of biological activities and industrial applications.
Innovation Solution
A method is developed for biosynthesizing violacein and its analogues using genetically modified host cells, involving the use of enzymes and a chemical handle for enzymatic conversion, and includes steps for glycosylation and de-glycosylation to enhance production and isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional bacterial biosynthesis methods are used, then violacein can be produced through natural pathways, but the production efficiency and industrial scalability are insufficient
Solution Approach 1:
The patent divides the violacein biosynthetic pathway into discrete enzymatic steps (VioA, VioB, VioC, VioD, VioE enzymes) that can be independently optimized and expressed in heterologous host cells. This segmentation allows for modular genetic engineering approaches where individual pathway enzymes can be overexpressed or modified to enhance overall production efficiency and scalability for industrial manufacturing.
2Quantity of substance
If chemically synthesized violacein is produced, then large quantities can be obtained, but the complexity and cost of chemical synthesis increase
Solution Approach 1:
The patent replaces complex chemical synthesis mechanisms with biological enzymatic mechanisms. By expressing the native violacein biosynthetic pathway enzymes in genetically engineered host cells, the system uses biological catalysis instead of multi-step chemical reactions, thereby simplifying the overall synthesis process while maintaining high product quantity and reducing manufacturing complexity.
3Adaptability or versatility
If violacein analogues and derivatives are produced through traditional methods, then structural diversity can be achieved, but the availability of specific compounds remains limited
Solution Approach 1:
The patent applies local quality modifications by introducing site-specific mutations in the violacein biosynthetic pathway enzymes (particularly VioA, VioB, and VioC) to generate structured diversity in violacein analogues and derivatives. This allows for targeted modification of specific molecular features while maintaining reliable production of desired compounds through controlled expression in engineered host cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a commercially viable access to violacein and its derivatives, enabling their use in dyeing textiles, enhancing antimicrobial and antioxidant properties, and providing UV resistance.
Implementation Method 1
contacting the indole of formula (II) with one or more enzymes, optionally wherein the one or more enzymes are from an operative biosynthetic pathway for producing violacein
Data Source
AI summary
The present invention relates to methods for making compounds of formula (I) including violacein, violacein analogues and derivatives thereof, and to compositions, cells, and fermentation liquids comprising the compounds resulting from these methods.